These results provide evidence for the in vivo relevance of Tc1 cells in the visceral fat of obese patients with dysglycemia, showing that fine-tuning of CD8 T cell effector functions may be harmful to the development of obesity-induced type 2 diabetes. This evidence concerns the gene CD8A and type 2 diabetes mellitus.